Cyclooxygenase-2 and Hypoxia-Inducible Factor-1α protein expression is related to inflammation, and up-regulated since the early steps of colorectal carcinogenesis

Cancer Letters

Volumn 279, Issue 2, 2009, Pages 221-229

  Mariani, Francesco ^a   Sena, Paola ^a   Marzona, Laura ^a   Riccio, Massimo ^a   Fano, Rita ^a   Manni, Paola ^a   Gregorio, Carmela Di ^b   Pezzi, Annalisa ^a   Leon, Maurizio Ponz de ^a   Monni, Sebastiano ^a   Pol, Anto De ^a   Roncucci, Luca ^a  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^b Department of Pathology   (Italy)

Author keywords

Colorectal tumourigenesis; COX 2; HIF 1 ; Immunocytochemistry; MPO

Indexed keywords

CYCLOOXYGENASE 2; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MYELOPEROXIDASE;

ARTICLE; CARCINOGENESIS; CELL INFILTRATION; COLON MUCOSA; COLONOSCOPY; COLORECTAL ADENOMA; COLORECTAL CANCER; COLORECTAL CARCINOMA; COLORECTAL TUMOR; CONTROLLED STUDY; CRYPT CELL; DYSPLASIA; ENTERITIS; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE MICROSCOPY; IMMUNOHISTOCHEMISTRY; MUCOSA INFLAMMATION; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; RECTUM MUCOSA;

COLORECTAL NEOPLASMS; CYCLOOXYGENASE 2; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; INFLAMMATORY BOWEL DISEASES; INTESTINAL MUCOSA; PEROXIDASE; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION;

EID: 67349221477     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2009.02.001     Document Type: Article

References (49)

1. Bruce W.R., Giacca A., and Medline A. Possible mechanisms relating diet and risk of colon cancer. Cancer Epidemiol. Biomarkers Prev. 9 12 (2000) 1271-1279
2. Ropponen K.M., Eskelinen M.J., Lipponen P.K., Alhava E., and Kosma V.M. Prognostic value of tumour-infiltrating lymphocytes (TILs) in colorectal cancer. J. Pathol. 182 3 (1997) 318-324
3. Knaapen A.M., Güngör N., Schins R.P., Borm P.J., and Van Schooten F.J. Neutrophils and respiratory tract DNA damage and mutagenesis: a review. Mutagenesis 21 4 (2006) 225-236
4. Krawisz J.E., Sharon P., and Stenson W.F. Quantitative assay for acute intestinal inflammation based on myeloperoxidase activity. Assessment of inflammation in rat and hamster models. Gastroenterology 87 (1984) 1344-1350
5. Smith W.L., Garavito R.M., and DeWitt D.L. Prostaglandin endoperoxide H synthases (cyclooxygenases)-1 and -2. J. Biol. Chem. 271 52 (1996) 33157-33160 December 27
6. Takahashi T., Takasuka N., Iigo M., Baba M., Nishino H., Tsuda H., and Okuyama T. Isoliquiritigenin, a flavonoid from licorice, reduces prostaglandin E2 and nitric oxide, causes apoptosis, and suppresses aberrant crypt foci development. Cancer Sci. 95 5 (2004) 448-453
7. Levy B.D., Clish C.B., Schmidt B., Gronert K., and Serhan C.N. Lipid mediator class switching during acute inflammation: signals in resolution. Nat. Immunol. 2 7 (2001) 612-619
8. Eberhart C.E., Coffey R.J., Radhika A., Giardiello F.M., Ferrenbach S., and DuBois R.N. Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology 107 4 (1994) 1183-2118
9. Sun Y., Tang X.M., Half E., Kuo M.T., and Sinicrope F.A. Cyclooxygenase-2 overexpression reduces apoptotic susceptibility by inhibiting the cytochrome c-dependent apoptotic pathway in human colon cancer cells. Cancer Res. 62 21 (2002) 6323-6638
10. Kaidi A., Qualtrough D., Williams A.C., and Paraskeva C. Direct transcriptional up-regulation of cyclooxygenase-2 by hypoxia-inducible factor (HIF)-1 promotes colorectal tumor cell survival and enhances HIF-1 transcriptional activity during hypoxia. Cancer Res. 66 13 (2006) 6683-6691
11. Cramer T., Yamanishi Y., Clausen B.E., Förster I., Pawlinski R., Mackman N., Haase V.H., Jaenisch R., Corr M., Nizet V., Firestein G.S., Gerber H.P., Ferrara N., and Johnson R.S. HIF-1alpha is essential for myeloid cell-mediated inflammation. Cell 112 5 (2003) 645-657
12. Saadi S., Wrenshall L.E., and Platt J.L. Regional manifestations and control of the immune system. FASEB J. 16 8 (2002) 849-856
13. Kruschewski M., Foitzik T., Perez-Cantó A., Hübotter A., and Buhr H.J. Changes of colonic mucosal microcirculation and histology in two colitis models: an experimental study using intravital microscopy and a new histological scoring system. Dis. Sci. 46 11 (2001) 2336-2343
14. Wang G.L., and Semenza G.L. Characterization of hypoxia-inducible factor 1 and regulation of DNA binding activity by hypoxia. J. Biol. Chem. 268 29 (1993) 21513-21518
15. Zhong H., De Marzo A.M., Laughner E., Lim M., Hilton D.A., Zagzag D., Buechler P., Isaacs W.B., Semenza G.L., and Simons J.W. Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases. Cancer Res. 59 22 (1999) 5830-5835
16. Buermeyer A.B., Deschênes S.M., Baker S.M., and Liskay R.M. Mammalian DNA mismatch repair. Annu. Rev. Genet. 33 (1999) 533-564
17. Mihaylova V.T., Bindra R.S., Yuan J., Campisi D., Narayanan L., Jensen R., Giordano F., Johnson R.S., Rockwell S., and Glazer P.M. Decreased expression of the DNA mismatch repair gene Mlh1 under hypoxic stress in mammalian cells. Mol. Cell. Biol. 23 9 (2003) 3265-3273
18. Boughton-Smith N.K., Wallace J.L., and Whittle B.J. Relationship between arachidonic acid metabolism myeloperoxidase activity and leukocyte infiltration in a rat model of inflammatory bowel disease. Agents Actions 25 1-2 (1988) 115-123
19. Roncucci L., Mora E., Mariani F., Bursi S., Pezzi A., Rossi G., Pedroni M., Luppi D., Santoro L., Monni S., Manenti A., Bertani A., Merighi A., Benatti P., Di Gregorio C., and Ponz de Leon M. Myeloperoxidase-positive cell infiltration in colorectal carcinogenesis as indicator of colorectal cancer risk. Cancer Epidemiol Biomarkers Prev 17 (2008) 2291-2297
20. Roncucci L., Medline A., and Bruce W.R. Classification of aberrant crypt foci and microadenomas in human colon. Cancer Epidemiol. Biomarkers Prev. 1 (1991) 57-60
21. Di Gregorio C., Losi L., Fante R., Modica S., Ghidoni M., Pedroni M., Tamassia M.G., Gafà L., Ponz de Leon M., and Roncucci L. Histology of aberrant crypt foci in the human colon. Histopathology 30 (1997) 328-334
22. Yoshimura H., Dhar D.K., Kohno H., Kubota H., Fujii T., Ueda S., Kinugasa S., Tachibana M., and Nagasue N. Prognostic impact of hypoxia-inducible factors 1alpha and 2alpha in colorectal cancer patients: correlation with tumor angiogenesis and cyclooxygenase-2 expression. Clin. Cancer Res. 10 24 (2004) 8554-8560
23. Pedroni M., Roncari B., Maffei S., et al. A mononucleotide markers panel to identify hMLH1/hMSH2 germline mutations. Disease Markers 23 (2007) 179-187
24. Glantz S.A. In: Glantz S.A. (Ed). Primer of Biostatistics. fivth ed. (2003), Mc-Graw Hill, New York
25. Cohen J. A coefficient of agreement for nominal scales. Educational Psychol. Measure. 20 (1960) 37-46
26. Sinicrope F.A., Lemoine M., Xi L., Lynch P.M., Cleary K.R., Shen Y., and Frazier M.L.. Reduced expression of cyclooxygenase 2 proteins in hereditary nonpolyposis colorectal cancers relative to sporadic cancers. Gastroenterology 117 2 (1999) 350-358
27. Sano H., Kawahito Y., Wilder R.L., Hashiramoto A., Mukai S., Asai K., Kimura S., Kato H., Kondo M., and Hla T. Expression of cyclooxygenase-1 and -2 in human colorectal cancer. Cancer Res. 55 17 (1995) 3785-3789
28. Jänne P.A., and Mayer R.J. Chemoprevention of colorectal cancer. New Engl J Med 342 26 (2000) 1960-1968 Review
29. Khan K.N., Masferrer J.L., Woerner B.M., Soslow R., and Koki A.T. Enhanced cyclooxygenase-2 expression in sporadic and familial adenomatous polyposis of the human colon. Scand. J. Gastroenterol. 36 8 (2001) 865-869
30. Wu A.W., Gu J., Ji J.F., Li Z.F., and Xu G.W. Role of COX-2 in carcinogenesis of colorectal cancer and its relationship with tumor biological characteristics and patients' prognosis. World J. Gastroenterol. 9 9 (2003) 1990-1994
31. Adegboyega P.A., Ololade O., Saada J., Mifflin R., Di Mari J.F., and Powell D.W. Subepithelial myofibroblasts express cyclooxygenase-2 in colorectal tubular adenomas. Clin. Cancer Res. 10 17 (2004) 5870-5879
32. Jiang C.Q., Fan L.F., Liu Z.S., Qian Q., Xia D., Diao L.M., He Y.M., and Ai Z.L. Expression levels and significance of hypoxia inducible factor-1 alpha and vascular endothelial growth factor in human colorectal adenocarcinoma. Chin. Med. J. (Engl) 117 10 (2004) 1541-1546
33. Wincewicz A., Sulkowska M., Koda M., and Sulkowski S. Cumulative expression of HIF-1-alpha Bax, Bcl-xL and P53 in human colorectal cancer. Pathology 39 3 (2007) 334-338
34. Koda M., Sulkowska M., Kanczuga-Koda L., Cascio S., Colucci G., Russo A., Surmacz E., and Sulkowski S. Expression of the obesity hormone leptin and its receptor correlates with hypoxia-inducible factor-1 alpha in human colorectal cancer. Ann. Oncol. 18 Suppl. 6 (2007) 116-119
35. Taylor C.T., and Colgan S.P. Therapeutic targets for hypoxia-elicited pathways. Pharm. Res. 16 10 (1999) 1498-1505 Review
36. Greijer A.E., Delis-van Diemen P.M., Fijneman R.J., Giles R.H., Voest E.E., van Hinsbergh V.W., and Meijer G.A. Presence of HIF-1 and related genes in normal mucosa, adenomas and carcinomas of the colorectum. Virchows Arch. 20 (2008) [Epub ahead of print]
37. Hendel J., and Nielsen O.H. Expression of cyclooxygenase-2 mRNA in active inflammatory bowel disease. Am. J. Gastroenterol. 92 7 (1997) 1170-1173
38. Thornton M., and Solomon M.J. Crohn's disease: in defense of a microvascular aetiology. Int. J. Colorectal Dis. 17 5 (2002) 287-297
39. Robinson A., Keely S., Karhausen J., et al. Mucosal protection by hypoxia-inducible factor prolyl hydroxylase inhibition. Gastroenterology 134 (2008) 145-155
40. Dong M., Guda K., Nambiar P.R., Rezaie A., Belinsky G.S., Lambeau G., Giardina C., and Rosenberg D.W. Inverse association between phospholipase A2 and COX-2 expression during mouse colon tumorigenesis. Carcinogenesis 24 2 (2003) 307-315
41. Kawasaki T., Nosho K., Ohnishi M., Suemoto Y., Glickman J.N., Chan A.T., Kirkner G.J., Mino-Kenudson M., Fuchs C.S., and Ogino S. Cyclooxygenase-2 overexpression is common in errated on-serrated colorectal denoma but uncommon in hyperplastic polyp and sessile serrated polyp/adenoma. BMC Cancer 29 (2008) 8-33
42. Chapple K.S., Cartwright E.J., Hawcroft G., Tisbury A., Bonifer C., Scott N., Windsor A.C., Guillou P.J., Markham A.F., Coletta P.L., and Hull M.A. Localization of cyclooxygenase-2 in human sporadic colorectal adenomas. Am. J. Pathol. 156 2 (2000) 545-553
43. Soumaoro L.T., Uetake H., Higuchi T., Takagi Y., Enomoto M., and Sugihara K. Cyclooxygenase-2 expression: a significant prognostic indicator for patients with colorectal cancer. Clin. Cancer Res. 10 24 (2004) 8465-8471
44. Xiong B., Sun T.J., Hu W.D., Cheng F.L., Mao M., and Zhou Y.F. Expression of cyclooxygenase-2 in colorectal cancer and its clinical significance. World J. Gastroenterol. 11 8 (2005) 1105-1108
45. Lim S.C., Lee T.B., Choi C.H., Ryu S.Y., Kim K.J., and Min Y.D. Expression of cyclooxygenase-2 and its relationship to p53 accumulation in colorectal cancers. Yonsei Med. J. 48 3 (2007) 495-501
46. Konno H., Baba M., Shoji T., Ohta M., Suzuki S., and Nakamura S. Cyclooxygenase-2 expression correlates with uPAR levels and is responsible for poor prognosis of colorectal cancer. Clin. Exp. Metastas. 19 6 (2002) 527-534
47. Tomozawa S., Tsuno N.H., Sunami E., Hatano K., Kitayama J., Osada T., Saito S., Tsuruo T., Shibata Y., and Nagawa H. Cyclooxygenase-2 overexpression correlates with tumour recurrence, especially haematogenous metastasis, of colorectal cancer. Br. J. Cancer 83 3 (2003) 24-28
48. Karnes Jr. W.E., Shattuck-Brandt R., Burgart L.J., et al. Reduced COX-2 protein in colorectal cancer with defective mismatch repair. Cancer Res. 58 (1998) 5473-5477
49. Furlan D., Sahnane N., Carnevali I., Cerutti R., Uccella S., Bertolini V., Chiaravalli A.M., and Capella C. Up-regulation and stabilization of HIF-1alpha in colorectal carcinomas. Surg Oncol. 16 Suppl. 1 (2007) S25-S27